Notifying Changes To Marketed Devices In Singapore Becomes Easier
This article was originally published in Clinica
Singapore's Health Sciences Authority has adopted a revised policy that makes it easier for medical device companies to notify the agency of any changes they make concerning a marketed device. The revised policy, issued in the form of an updated guidance, applies to "change notification" applications submitted by companies as of Dec. 1, when the policy came into effect.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.